At House Oversight Hearing, California's Medicaid Director Testifies CMS Cited 'No Instances of Fraud' to Justify Its $1.3B Medi-Cal Deferral
At a House Energy & Commerce oversight subcommittee hearing on June 25, 2026, California Medicaid Director Tyler Sadwith testified that despite CMS's May deferral of roughly $1.3 billion in federal Medicaid funds — the largest such deferral in CMS history, aimed mainly at in-home/personal-care (IHSS) spending — 'CMS decided to defer the payments, and they have not provided any instances of fraud, waste or abuse as part of their review.'
Sadwith noted California has suspended approximately 5,000 providers for fraud over the past five years and recovered more than $1 billion in fraudulent payments over the past three; Minnesota's Medicaid director testified about a $350 million deferral there, with CMS threatening to withhold $2 billion annually. Democrats characterized the CMS actions as politically targeted, while Republicans defended the administration's anti-fraud posture.
For FQHCs, the hearing sharpens a fact implicit in the original deferral: the withheld dollars are not (yet) tied to any documented fraud finding, even as the freeze tightens the Medi-Cal cash pool the safety net draws on.
Part of
- Medicaid financing and eligibility operations
CMS deferrals and program-integrity actions
Key points
- Sadwith's testimony: CMS 'decided to defer the payments, and they have not provided any instances of fraud, waste or abuse as part of their review.'
- California has suspended ~5,000 providers for fraud over five years and recovered over $1B in three years — context Sadwith cited to rebut the deferral's rationale.
- The deferral remains unresolved, keeping Medi-Cal's fiscal picture tight for every provider, FQHCs included, even absent a documented fraud finding.
Sources for this story
Healthcare DiveSources for your board packet
This story's source plus 4 related stories and their sources, ready to print for your team or board.
Free. Unlocking the packet subscribes you to Intel Brief. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.
FQHC Talent. (2026, June 25). At House Oversight Hearing, California's Medicaid Director Testifies CMS Cited 'No Instances of Fraud' to Justify Its $1.3B Medi-Cal Deferral. Source: Healthcare Dive. Retrieved September 28, 2026, from https://www.fqhctalent.com/intel/house-hearing-sadwith-testimony-no-fraud-cited-medi-cal-deferral-june-2026
More in Funding & Budget
Sep 24
HRSA extends funding for 272 health centers in the FY2027 Service Area Competition
Sep 21
Comments on CMS's provider-tax implementation rule closed September 21 with no extension; the final rule is the next step
Sep 18
40 states and Puerto Rico sign on to CMS's GENEROUS Medicaid drug-pricing model; the rest have until September 30
Sep 14
Johnson & Johnson requires claims data on every 340B dispense and extends its contract-pharmacy policy to grantees on November 3